These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18798086)

  • 1. Preparation and characterization of silica xerogels as carriers for drugs.
    Czarnobaj K
    Drug Deliv; 2008 Nov; 15(8):485-92. PubMed ID: 18798086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silica-polyethylene glycol matrix synthesis by sol-gel method and evaluation for diclofenac diethyloammonium release.
    Prokopowicz M
    Drug Deliv; 2007 Mar; 14(3):129-38. PubMed ID: 17454032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sol-gel processed porous silica carriers for the controlled release of diclofenac diethylamine.
    Czarnobaj K; Czarnobaj J
    J Biomed Mater Res B Appl Biomater; 2008 Oct; 87(1):114-20. PubMed ID: 18437709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro controlled release of doxorubicin from silica xerogels.
    Prokopowicz M
    J Pharm Pharmacol; 2007 Oct; 59(10):1365-73. PubMed ID: 17910811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug.
    Prokopowicz M
    Acta Biomater; 2009 Jan; 5(1):193-207. PubMed ID: 18755642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior.
    Yilmaz E; Bengisu M
    J Biomed Mater Res B Appl Biomater; 2006 Apr; 77(1):149-55. PubMed ID: 16222698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Encapsulation of diclofenac sodium within polymer beads by silica species via vapour-phase synthesis.
    Kierys A; Kasperek R; Krasucka P; Goworek J
    Colloids Surf B Biointerfaces; 2016 Jun; 142():30-37. PubMed ID: 26925723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro release of cisplatin from sol-gel processed organically modified silica xerogels.
    Czarnobaj K; Lukasiak J
    J Mater Sci Mater Med; 2007 Oct; 18(10):2041-4. PubMed ID: 17558477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Na(2)CO(3), NaF and NH(4)OH on the stability and release behavior of sol-gel derived silica xerogels embedded with bioactive compounds.
    Morpurgo M; Teoli D; Pignatto M; Attrezzi M; Spadaro F; Realdon N
    Acta Biomater; 2010 Jun; 6(6):2246-53. PubMed ID: 20035908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of amorphous microporous silica for ibuprofen controlled release.
    Aerts CA; Verraedt E; Depla A; Follens L; Froyen L; Van Humbeeck J; Augustijns P; Van den Mooter G; Mellaerts R; Martens JA
    Int J Pharm; 2010 Sep; 397(1-2):84-91. PubMed ID: 20619331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of synthesis and processing conditions on the release behavior and stability of sol-gel derived silica xerogels embedded with bioactive compounds.
    Morpurgo M; Teoli D; Palazzo B; Bergamin E; Realdon N; Guglielmi M
    Farmaco; 2005 Aug; 60(8):675-83. PubMed ID: 15979615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine.
    Wen LX; Ding HM; Wang JX; Chen JF
    J Nanosci Nanotechnol; 2006; 6(9-10):3139-44. PubMed ID: 17048529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
    Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
    Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
    Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid organic-inorganic silica gel carriers with controlled drug-delivery properties.
    Contessotto L; Ghedini E; Pinna F; Signoretto M; Cerrato G; Crocellà V
    Chemistry; 2009 Nov; 15(44):12043-9. PubMed ID: 19774561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel mesoporous silica nanoparticles for loading and release of ibuprofen.
    Zhang H; Li Z; Xu P; Wu R; Wang L; Xiang Y; Jiao Z
    J Control Release; 2011 Nov; 152 Suppl 1():e38-9. PubMed ID: 22195911
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation role of ibuprofen toward the morphology of porous silica nanospheres during its in situ encapsulation.
    Du X; He J
    J Colloid Interface Sci; 2010 May; 345(2):269-77. PubMed ID: 20219205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanocapsule@xerogel microparticles containing sodium diclofenac: a new strategy to control the release of drugs.
    da Fonseca LS; Silveira RP; Deboni AM; Benvenutti EV; Costa TM; Guterres SS; Pohlmann AR
    Int J Pharm; 2008 Jun; 358(1-2):292-5. PubMed ID: 18358650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro bioactivity and degradation behavior of silica xerogels intended as controlled release materials.
    Radin S; Falaize S; Lee MH; Ducheyne P
    Biomaterials; 2002 Aug; 23(15):3113-22. PubMed ID: 12102182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
    Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
    Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.